Literature DB >> 22929866

The nosology of schizophrenia: toward DSM-5 and ICD-11.

Rajiv Tandon1.   

Abstract

Although dementia praecox or schizophrenia has been considered a unique disease entity for more than a century, definitions and boundaries have changed and its precise cause and pathophysiology remain elusive. Despite uncertain validity, the construct of schizophrenia conveys useful clinical and etiopathophysiologic information. Revisions of the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases seek to incorporate new information about schizophrenia and include elimination of subtypes, addition of psychopathological dimensions, elimination of special treatment of Schneiderian "first-rank" symptoms, better delineation of schizoaffective disorder, and addition of a new category of "attenuated psychosis syndrome". Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22929866     DOI: 10.1016/j.psc.2012.06.001

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  11 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Psychotic depression: an underappreciated window to explore the dimensionality and pathobiology of psychosis.

Authors:  John L Waddington; Peter F Buckley
Journal:  Schizophr Bull       Date:  2013-05-24       Impact factor: 9.306

3.  ICD-11 symposia at the World Congress of Psychiatry.

Authors:  Gaia Sampogna
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

4.  The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia.

Authors:  Ann K Shinn; Stephan Heckers; Dost Öngür
Journal:  Schizophr Res       Date:  2013-03-22       Impact factor: 4.939

5.  Re-conceptualizing ASD Within a Dimensional Framework: Positive, Negative, and Cognitive Feature Clusters.

Authors:  Jennifer H Foss-Feig; James C McPartland; Alan Anticevic; Julie Wolf
Journal:  J Autism Dev Disord       Date:  2016-01

Review 6.  New drug developments in psychosis: Challenges, opportunities and strategies.

Authors:  Matcheri S Keshavan; Ashley N Lawler; Henry A Nasrallah; Rajiv Tandon
Journal:  Prog Neurobiol       Date:  2016-08-09       Impact factor: 11.685

7.  Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia.

Authors:  Anna Michalczyk; Justyna Pełka-Wysiecka; Jolanta Kucharska-Mazur; Michał Wroński; Błażej Misiak; Jerzy Samochowiec
Journal:  Ann Gen Psychiatry       Date:  2020-06-17       Impact factor: 3.455

8.  Schizophrenia and Other Psychotic Disorders in Diagnostic and Statistical Manual of Mental Disorders (DSM)-5: Clinical Implications of Revisions from DSM-IV.

Authors:  Rajiv Tandon
Journal:  Indian J Psychol Med       Date:  2014-07

Review 9.  Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
.

Authors:  Jack R Foucher; Micha Gawlik; Julian N Roth; Clément de Crespin de Billy; Ludovic C Jeanjean; Alexandre Obrecht; Olivier Mainberger; Julie M E Clauss; Julien Elowe; Sébastien Weibel; Benoit Schorr; Marcelo Cetkovich; Carlos Morra; Federico Rebok; Thomas A Ban; Barbara Bollmann; Mathilde M Roser; Markus S Hanke; Burkhard E Jabs; Ernst J Franzek; Fabrice Berna; Bruno Pfuhlmann
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

Review 10.  Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.

Authors:  Anastasia Levchenko; Timur Nurgaliev; Alexander Kanapin; Anastasia Samsonova; Raul R Gainetdinov
Journal:  Heliyon       Date:  2020-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.